These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12496995

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 23. Doxazosin induces apoptosis in LNCaP prostate cancer cell line through DNA binding and DNA-dependent protein kinase down-regulation.
    Arencibia JM, Del Rio M, Bonnin A, Lopes R, Lemoine NR, López-Barahona M.
    Int J Oncol; 2005 Dec 01; 27(6):1617-23. PubMed ID: 16273218
    [Abstract] [Full Text] [Related]

  • 24. [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
    Liu SJ, Xu KX, Wang XF, Hou SK, Wang YC.
    Zhonghua Wai Ke Za Zhi; 2004 May 22; 42(10):604-6. PubMed ID: 15265404
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    Forbes A, Anoopkumar-Dukie S, Chess-Williams R, McDermott C.
    Prostate; 2016 Jun 22; 76(8):757-66. PubMed ID: 26880388
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA, McVary KT.
    Int J Impot Res; 2008 Dec 22; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [Abstract] [Full Text] [Related]

  • 31. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L, Kyprianou N.
    Prostate Cancer Prostatic Dis; 2005 Dec 22; 8(1):7-13. PubMed ID: 15477876
    [Abstract] [Full Text] [Related]

  • 32. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M, Sánchez C, Benitez DA, Contreras HR, Huidobro C, Cabezas J, Acevedo C, Castellón EA.
    Prostate; 2009 Jul 01; 69(10):1025-33. PubMed ID: 19301301
    [Abstract] [Full Text] [Related]

  • 33. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P.
    J Med Chem; 2009 Aug 13; 52(15):4951-4. PubMed ID: 19719240
    [Abstract] [Full Text] [Related]

  • 34. Anti-angiogenic effects and mechanism of prazosin.
    Liao CH, Guh JH, Chueh SC, Yu HJ.
    Prostate; 2011 Jun 15; 71(9):976-84. PubMed ID: 21541974
    [Abstract] [Full Text] [Related]

  • 35. Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor.
    Yamada D, Nishimatsu H, Kumano S, Hirano Y, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Kume H, Homma Y.
    Int J Urol; 2013 Dec 15; 20(12):1220-7. PubMed ID: 23600973
    [Abstract] [Full Text] [Related]

  • 36. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.
    Roehrborn CG, Schwinn DA.
    J Urol; 2004 Mar 15; 171(3):1029-35. PubMed ID: 14767264
    [Abstract] [Full Text] [Related]

  • 37. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 38. Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients.
    Xue Z, Zhang Y, Ding Q, He Z, Wang J, Xu K.
    Int J Urol; 2007 Feb 15; 14(2):118-22. PubMed ID: 17302567
    [Abstract] [Full Text] [Related]

  • 39. Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
    van Dijk MM, de la Rosette JJ, Michel MC.
    Drugs; 2006 Feb 15; 66(3):287-301. PubMed ID: 16526818
    [Abstract] [Full Text] [Related]

  • 40. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K, Naruganahalli KS, Gupta S, Malhotra S, Tiwari A, Hegde LG, Jain S, Sinha N, Gupta JB, Chugh A, Anand N, Ray A.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):213-9. PubMed ID: 19239913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.